QAAHBX Holdings — T. Rowe Price Health Sciences Portfolio
All 277 reported holdings of T. Rowe Price Health Sciences Portfolio (QAAHBX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 14.06% | $105.69M |
| Johnson & Johnson | 6.64% | $49.90M |
| Unitedhealth Group, Inc. | 5.88% | $44.21M |
| Abbvie, Inc. | 5.12% | $38.51M |
| Merck & Co. Inc. | 4.00% | $30.04M |
| Gilead Sciences, Inc. | 2.79% | $21.01M |
| Thermo Fisher Scientific, Inc. | 2.53% | $19.04M |
| Vertex Pharmaceuticals, Inc. | 2.26% | $16.98M |
| Bristol-Myers Squibb Co. | 2.12% | $15.92M |
| Abbott Laboratories | 1.91% | $14.39M |
| Intuitive Surgical, Inc. | 1.89% | $14.17M |
| Amgen, Inc. | 1.80% | $13.55M |
| Stryker Corp. | 1.78% | $13.42M |
| Elevance Health, Inc. | 1.54% | $11.61M |
| Danaher Corp. | 1.44% | $10.81M |
| Natera, Inc. | 1.44% | $10.79M |
| Guardant Health, Inc. | 1.22% | $9.17M |
| Cardinal Health, Inc. | 1.04% | $7.82M |
| Royalty Pharma PLC- Cl A | 0.97% | $7.29M |
| Tenet Healthcare Corp. | 0.94% | $7.08M |
| Cvs Health Corp. | 0.93% | $6.99M |
| Kymera Therapeutics, Inc. | 0.89% | $6.69M |
| T. Rowe Price Government Reserve Fund | 0.87% | $6.51M |
| Protagonist Therapeutics, Inc. | 0.85% | $6.41M |
| Moderna Therapeutics, Inc. | 0.83% | $6.25M |
| Revolution Medicines, Inc. | 0.81% | $6.13M |
| Brightspring Health Services | 0.81% | $6.12M |
| Roivant Sciences Ltd. | 0.74% | $5.56M |
| Alnylam Pharmaceuticals, Inc. | 0.70% | $5.28M |
| Viatris, Inc. | 0.66% | $4.97M |
| Charles River Laboratories | 0.61% | $4.61M |
| Argenx SE - ADR | 0.60% | $4.49M |
| Edwards Lifesciences Corp. | 0.59% | $4.43M |
| Centene Corp. | 0.58% | $4.35M |
| Spyre Therapeutics Inc | 0.56% | $4.23M |
| Definium Therapeutics Inc | 0.51% | $3.82M |
| Insmed, Inc. | 0.49% | $3.70M |
| Chugai Pharmaceutical Co. Ltd. | 0.48% | $3.64M |
| Astrazeneca PLC | 0.48% | $3.59M |
| Twist Bioscience Corp. | 0.48% | $3.58M |
| Boston Scientific Corp. | 0.46% | $3.43M |
| Medtronic PLC | 0.44% | $3.33M |
| United Therapeutics Corp. | 0.44% | $3.32M |
| Krystal Biotech, Inc. | 0.44% | $3.28M |
| Erasca, Inc. | 0.40% | $2.99M |
| Billiontoone, Inc. Cl A | 0.39% | $2.97M |
| Medpace Holdings, Inc. | 0.38% | $2.89M |
| Ascendis Pharma A/s | 0.38% | $2.88M |
| Scholar Rock Holding Corp. | 0.38% | $2.85M |
| Praxis Precision Medicines I | 0.38% | $2.85M |
| Beone Medicines Ltd. | 0.38% | $2.84M |
| Parabilis Medicines, Inc. Lockup Shares PP | 0.38% | $2.82M |
| Tango Therapeutics, Inc. | 0.37% | $2.77M |
| Oruka Therapeutics, Inc. | 0.37% | $2.75M |
| Monte Rosa Therapeutics, Inc. | 0.36% | $2.73M |
| Dianthus Therapeutics, Inc. | 0.36% | $2.71M |
| Humana, Inc. | 0.35% | $2.66M |
| Kodiak Sciences, Inc. | 0.33% | $2.49M |
| Axsome Therapeutics, Inc. | 0.32% | $2.40M |
| Relay Therapeutics, Inc. | 0.31% | $2.34M |
| Summit Therapeutics, Inc. | 0.31% | $2.31M |
| Cg Oncology, Inc. | 0.31% | $2.31M |
| Novo-Nordisk A/s-Spons ADR | 0.30% | $2.26M |
| Cytokinetics, Inc. | 0.30% | $2.23M |
| Vera Therapeutics, Inc. | 0.29% | $2.18M |
| Regeneron Pharmaceuticals | 0.29% | $2.18M |
| Ionis Pharmaceuticals, Inc. | 0.29% | $2.18M |
| Mbx Biosciences, Inc. | 0.29% | $2.15M |
| Agilent Technologies, Inc. | 0.28% | $2.09M |
| Enliven Therapeutics, Inc. | 0.27% | $2.05M |
| Crinetics Pharmaceuticals In | 0.27% | $2.00M |
| Mirum Pharmaceuticals, Inc. | 0.27% | $1.99M |
| Bridgebio Pharma, Inc. | 0.26% | $1.97M |
| Madrigal Pharmaceuticals, Inc. | 0.26% | $1.97M |
| Newamsterdam Pharma Co. NV | 0.26% | $1.95M |
| Waters Corp. | 0.26% | $1.95M |
| Nurix Therapeutics, Inc. | 0.26% | $1.92M |
| Beam Therapeutics, Inc. | 0.25% | $1.91M |
| Liquidia Corp. | 0.24% | $1.81M |
| Rhythm Pharmaceuticals, Inc. | 0.24% | $1.77M |
| West Pharmaceutical Services | 0.23% | $1.72M |
| Ideaya Biosciences, Inc. | 0.23% | $1.70M |
| Viridian Therapeutics, Inc. | 0.22% | $1.68M |
| Teva Pharmaceutical-Sp ADR | 0.22% | $1.68M |
| Alkermes PLC | 0.22% | $1.67M |
| Immunome, Inc. | 0.22% | $1.66M |
| Alignment Healthcare, Inc. | 0.22% | $1.64M |
| Rapport Therapeutics, Inc. | 0.21% | $1.59M |
| Vaxcyte, Inc. | 0.20% | $1.52M |
| Palvella Therapeutics, Inc. | 0.20% | $1.50M |
| Structure Therapeutics, Inc. ADR | 0.18% | $1.39M |
| Immunocore Holdings PLC-ADR | 0.18% | $1.38M |
| Climb Bio Inc | 0.18% | $1.34M |
| Icon PLC | 0.17% | $1.30M |
| Celldex Therapeutics, Inc. | 0.17% | $1.25M |
| Kailera Therapeutics, Inc. | 0.16% | $1.23M |
| Bicara Therapeutics, Inc. | 0.16% | $1.22M |
| Oric Pharmaceuticals, Inc. | 0.15% | $1.16M |
| Treeline Bio Ser A-1 Cvt Pfd Stock Pp | 0.15% | $1.14M |
| Aktis Oncology Inc. Lockup Shs PP | 0.15% | $1.14M |
| Generate Biomedicines Inc Lockup Shs PP | 0.15% | $1.13M |
| Encompass Health Corp. | 0.15% | $1.11M |
| Moonlake Immunotherapeutics | 0.14% | $1.08M |
| Cencora, Inc. | 0.14% | $1.07M |
| Alumis, Inc. | 0.14% | $1.06M |
| Abivax SA-ADR | 0.14% | $1.06M |
| Apogee Therapeutics, Inc. | 0.14% | $1.05M |
| Sonova Holding AG-Reg | 0.14% | $1.04M |
| Veeva Systems, Inc. Cl A | 0.13% | $1.01M |
| Ocular Therapeutix, Inc. | 0.13% | $988.93K |
| Treeline Bio Ser A Cvt Pfd Stock Pp | 0.13% | $984.25K |
| Cogent Biosciences, Inc. | 0.13% | $972.72K |
| Stoke Therapeutics, Inc. | 0.13% | $959.09K |
| Shattuck Labs, Inc. | 0.13% | $950.50K |
| Biohaven Ltd. | 0.12% | $901.62K |
| Arrowhead Pharmaceuticals, Inc. | 0.12% | $871.26K |
| Immix Biopharma, Inc. | 0.11% | $851.74K |
| Incyte Corp. | 0.11% | $844.99K |
| Belite Bio, Inc. - ADR | 0.11% | $831.52K |
| Parabilis Medicines, Inc. | 0.11% | $830.90K |
| Iqvia Holdings, Inc. | 0.11% | $821.76K |
| Avalyn Pharma Inc Lockup Shares PP | 0.11% | $818.95K |
| Kailera Therapeutics Inc Lockup Shares PP | 0.11% | $806.41K |
| Avalyn Pharma, Inc. | 0.11% | $802.46K |
| Seaport Therapeutics Inc Lockup Shares PP | 0.10% | $785.74K |
| Sionna Therapeutics, Inc. | 0.10% | $783.33K |
| Cullinan Therapeutics Inc | 0.10% | $781.21K |
| Quest Diagnostics, Inc. | 0.10% | $764.93K |
| Cellanome Series A Cvt Pfd Stock Pp | 0.10% | $762.73K |
| Denali Therapeutics, Inc. | 0.10% | $754.88K |
| Biontech SE-ADR | 0.10% | $735.10K |
| Corvus Pharmaceuticals, Inc. | 0.10% | $728.53K |
| Insitro Ser B Cvt Pfd Pp | 0.10% | $727.86K |
| Pharvaris NV | 0.09% | $711.79K |
| Tarsus Pharmaceuticals, Inc. | 0.09% | $697.19K |
| Genesis Molecular AI Ser B CVT PFD PP | 0.09% | $679.99K |
| Galvanize Thera Ser C-1 Cvt Pfd Pp | 0.09% | $678.96K |
| Immunocore Holdings Cb 2.50% 2/30 | 0.09% | $670.20K |
| Disc Medicine, Inc. | 0.09% | $659.94K |
| Arsenal Biosciences Ser C Cvt Pfd Pp | 0.09% | $650.73K |
| Aktis Oncology, Inc. | 0.09% | $645.02K |
| Tenax Therapeutics, Inc. | 0.08% | $626.17K |
| Delfi Diagnostics Sr A Cvt Pfd Stock Pp | 0.08% | $604.19K |
| Mirum Pharma 6 month Lockup Shs PP | 0.08% | $602.35K |
| Mirum Pharma 9 month Lockup Shs PP | 0.08% | $602.46K |
| Tyra Biosciences, Inc. | 0.08% | $600.47K |
| Atrium Therapeutics, Inc. | 0.07% | $560.87K |
| Endeavor Bio Series B Cvt Pfd Stock Pp | 0.07% | $550.05K |
| Clear Labs Series C Cvt Pfd Pp | 0.07% | $542.40K |
| Avalo Therapeutics, Inc. | 0.07% | $537.40K |
| Nanobiotix | 0.07% | $527.50K |
| Olema Pharmaceuticals, Inc. | 0.07% | $509.12K |
| Allogene Therapeutics, Inc. | 0.07% | $506.00K |
| Third Arc Bio Ser A Cvt Pfd Pp | 0.07% | $505.10K |
| Wave Life Sciences Ltd. | 0.07% | $493.81K |
| Kyverna Therapeutics, Inc. | 0.07% | $491.59K |
| Kartos Therapeutics Sr C Cvt Pfd Stk Pp | 0.06% | $485.75K |
| Insitro Ser C Cvt Pfd Pp | 0.06% | $480.73K |
| National Resilience Sr B Cvt Pfd Stk Pp | 0.06% | $468.74K |
| Hemab Therapeutics Holdings | 0.06% | $467.90K |
| Cleerly Ser C Cvt Pfd Stk Pp | 0.06% | $465.65K |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | 0.06% | $460.45K |
| Alto Neuroscience, Inc. | 0.06% | $432.80K |
| Element Biosciences Ser C Cvt Pfd Stock Pp | 0.06% | $428.19K |
| Procept Biorobotics Corp. | 0.05% | $405.11K |
| Seaport Therapeutics, Inc. | 0.05% | $400.10K |
| Adaptive Biotechnologies | 0.05% | $395.58K |
| Spyglass Pharma, Inc. | 0.05% | $388.44K |
| Iovance Biotherapeutics, Inc. | 0.05% | $385.42K |
| Celcuity, Inc. | 0.05% | $385.21K |
| Kardium Inc Series D-7 CVT PFD Stock PP | 0.05% | $378.06K |
| Xencor, Inc. | 0.05% | $367.93K |
| Nchroma Bio Ser I Cvt Pfd Stock Pp | 0.05% | $355.00K |
| Cabaletta Bio, Inc. | 0.05% | $344.17K |
| Obsidian Therapeutic Sr C Cvt Pfd Stk Pp | 0.04% | $338.03K |
| Kardium, Inc. Ser D-5 Cvt Pfd Stock Pp | 0.04% | $330.77K |
| Delfi Diagnostics Sr B Cvt Pfd Stock Pp | 0.04% | $328.85K |
| Generate Biomedicines, Inc. | 0.04% | $322.47K |
| Inspire Medical Systems, Inc. | 0.04% | $321.19K |
| Evommune, Inc. | 0.04% | $317.83K |
| Crescent Biopharma, Inc. | 0.04% | $317.36K |
| Grs - Security Lending Collateral | 0.04% | $309.14K |
| Galvanize Therapeutics Ser C CVT PFD PP | 0.04% | $304.54K |
| Genesis Molecular AI Ser A CVT PFD PP | 0.04% | $279.68K |
| Scribe Thera Ser B Cvt Pfd Stock Pp | 0.04% | $277.64K |
| Eikon Therapeutics, Inc. | 0.04% | $273.74K |
| Bicycle Therapeutics PLC-ADR | 0.04% | $266.47K |
| Deepsight Tech Inc SER C CVT PFD PP | 0.04% | $264.30K |
| SPAC PCSC Freenome PIPE COMMIT PP | 0.03% | $255.47K |
| National Resilience Sr C Cvt Pfd Stk Pp | 0.03% | $255.49K |
| Kardium Inc Series D-8 CVT PFD Stock PP | 0.03% | $241.59K |
| Sensorion SA | 0.03% | $230.92K |
| Color Health Sr D-1 Cvt Pfd Stock Pp | 0.03% | $230.89K |
| Color Health Sr D Cvt Pfd Stock Pp | 0.03% | $227.60K |
| Eikon Therapeutics, Inc Lockup Shs PP | 0.03% | $218.47K |
| Xenon Pharmaceuticals, Inc. | 0.03% | $211.26K |
| Odyssey Therapeutics, Inc. | 0.03% | $210.97K |
| Agios Pharmaceuticals, Inc. | 0.03% | $209.93K |
| Immatics NV | 0.03% | $209.69K |
| Freenome Holdings Ser B Cvt Pfd Pp | 0.03% | $206.73K |
| Biomarin Pharmaceutical | 0.03% | $205.99K |
| Ge Healthcare Technologies, Inc. | 0.02% | $179.23K |
| Immuneering Corp. - Class A | 0.02% | $178.82K |
| Manus Bio, Inc. Series One-6 Cvt Pfd Pp | 0.02% | $177.66K |
| Odyssey Therapeutics Inc Lockup Shares PP | 0.02% | $172.75K |
| Treeline Bio SER A-2 CVT PFD PP | 0.02% | $161.12K |
| Tessera Therapeutics Ser C' Cvt Pfd Pp | 0.02% | $157.67K |
| Dyne Therapeutics, Inc. | 0.02% | $157.69K |
| Caris Life Sciences, Inc. | 0.02% | $157.08K |
| Endeavor Bio Ser C Cvt Pfd Pp | 0.02% | $154.16K |
| Kartos Therapeutics SR D CVT PFD STK PP | 0.02% | $153.12K |
| Entrada Therapeutics, Inc. | 0.02% | $148.37K |
| Mirum Pharma Indemnity Holdback Shs PP | 0.02% | $134.57K |
| Freenome Holdings Ser C Cvt Pfd Pp | 0.02% | $120.83K |
| Element Biosciences Ser D Cvt Pfd Pp | 0.02% | $121.06K |
| Element Biosciences Ser D-1 Cvt Pfd Pp | 0.02% | $121.06K |
| BridgeBio Oncology Therapeutics Inc | 0.02% | $120.20K |
| Arbor Bio Series B Cvt Pfd Stock Pp | 0.01% | $108.45K |
| Revolution Medicines, Inc. Wts 12/26 | 0.01% | $104.30K |
| Pax Labs Class A Common Pp | 0.01% | $104.13K |
| Lumicks Tech Ser D Cvt Pfd Stock Pp | 0.01% | $96.62K |
| Maplight Therapeutics, Inc. | 0.01% | $92.32K |
| Tessera Therapeutics Ser D Cvt Pfd Pp | 0.01% | $89.34K |
| Dna Script Series C Cvt Pfd Stock Pp | 0.01% | $81.20K |
| Delfi Diagnostics CVT Prom Note PP | 0.01% | $78.28K |
| Color Health Series E Cvt Pfd Stock Pp | 0.01% | $76.97K |
| Tectonic Therapeutic, Inc. | 0.01% | $71.53K |
| Aura Biosciences, Inc. | 0.01% | $70.35K |
| Arbor Bio Series C Cvt Pfd Stock Pp | 0.01% | $71.03K |
| Freenome Holdings Ser D Cvt Pfd Pp | 0.01% | $68.53K |
| Saluda Medical Inc Lockup Shs CDI PP | 0.01% | $60.34K |
| Clear Labs Ser D Cvt Pfd Stock Pp | 0.01% | $57.97K |
| Verily Health, Inc. CL B Common Stock PP | 0.01% | $58.19K |
| Cabaletta Bio Common WTS 09/26 PP | 0.01% | $57.24K |
| Mirum Pharma Escrow Indemnity PP | 0.01% | $54.61K |
| Kartos Therapeutics CVT Prom Note 03/27 PP | 0.01% | $44.80K |
| Honor Technology Ser D Cvt Pfd Pp | 0.01% | $42.25K |
| Capsule Corp. Series E Cvt Pfd Stock Pp | 0.01% | $41.28K |
| Capsule Corp. Series 1-D Cvt Pfd Stock | 0.01% | $38.52K |
| Sail Biomedicines Ser B Cvt Pfd Stock Pp | 0.00% | $34.15K |
| Reflexion Med CVT Note issued 082725 PP | 0.00% | $32.78K |
| Reflexion Med CVT Note issued 072525 PP | 0.00% | $33.27K |
| Reflexion Med CVT Note issued 081325 PP | 0.00% | $33.03K |
| Profoundbio Escrow Fund Payment Pp | 0.00% | $31.95K |
| Honor Technology Ser E Cvt Pfd Stock Pp | 0.00% | $28.47K |
| Freenome Holdings Ser F Cvt Pfd Pp | 0.00% | $24.73K |
| Treeline Bio Common WTS 8/35 PP | 0.00% | $24.17K |
| Kartos Therapeutics CVT Note 05/27 PP | 0.00% | $11.45K |
| PROGNOMIQ INC CL A Common PP | 0.00% | $4.10K |
| Mirum Pharma Escrow Working Capital PP | 0.00% | $2.20K |
| Chromacode INC SER AA CVT PFD STK PP | 0.00% | $2.42K |
| Mirum Pharma Escrow Expense Fund PP | 0.00% | $2.20K |
| Affinivax Expense Fund Pp | 0.00% | $522 |
| Reflexion Medical, Inc. Cvt Pfd Sr D-X Pp | 0.00% | $66 |
| Reflexion Medical, Inc. Cvt Pfd Sr C-X Pp | 0.00% | $196 |
| Generation Bio Co. | 0.00% | $0 |
| Reflexion Medical Ser F Cvt Pfd Stock Pp | 0.00% | $83 |
| Blue Marlin Therapeutics Common Stock PP | 0.00% | $8 |
| Gyroscope Therapeutics Mlstne Pymt 1 Pp | 0.00% | $0 |
| Exact Sciences Cmo Milestone Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 2 Pp | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr E-X Pp | 0.00% | $117 |
| Ring Therapeutics, Inc. Pp | 0.00% | $0 |
| Profoundbio Expense Fund Payment Pp | 0.00% | $6 |
| Mirum Pharma Milestone $750 mil PP | 0.00% | $0 |
| Mirum Pharma Milestone $500 mil PP | 0.00% | $0 |
| Exact Sciences Fda Milestone Pp | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 3 Pp | 0.00% | $0 |
| Medici Tx Platform $3 mil Milestone PP | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 600 Pp | 0.00% | $0 |
| Affinivax Next Gen Prod Mileston Evnt Pp | 0.00% | $0 |
| Affinivax Afx3772 Milestone Event Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 700 Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Sh 800 Pp | 0.00% | $0 |
| Chromacode, Inc. Pp | 0.00% | $34 |
| Genedx Holdings Corp. Wts 7/26 | 0.00% | $33 |
| Somalogic, Inc. Wts 8/26 | 0.00% | $0 |
QAAHBX overview: performance, fees, allocation and SEC filings